Read more about the FTI JournalHealthcare & Life Sciences
Filter Articles
- View All
- Topics
- Automotive
- Media & Entertainment
- Construction
- Financial Services
- Healthcare & Life Sciences
- Insurance
- Retail
- Information Technology
- Restructuring & Turnaround
- Economics & Policy
- Regulation & Governance
- Government & Public Contracts
- Real Estate
- Aerospace & Defense
- Agriculture
- Energy & Chemicals
- Environmental
- Hospitality, Gaming & Leisure
- Mining
- Telecommunications
- Transportation
- Risk & Litigation
- Technology & Data
- Communications & Reputation
- Global Trade
- Management & Leadership
- Corporate Finance & Restructuring
- Forensic & Litigation Consulting
- Strategic Communications
- Global
- North America
- Latin America
- Europe
- Africa
- Middle East
- Asia / Pacific
- Business Transformation & Transactions
- Cybersecurity
-
![Home Is Where The Health Is]()
Home Is Where The Health Is
What mid- to long-term investment opportunities are expected to emerge in the home healthcare market following COVID-19?
-
![Snapshot of the Pandemic: Is the Weather Affecting Your Social Distancing?]()
Snapshot of the Pandemic: Is the Weather Affecting Your Social Distancing?
An FTI review of social distancing complaints in New York City reveals how much the weather can impact behavior. What does it mean for Americans as the summer months unfold?
-
![The Life-Saving Intersection of Healthcare and Cybersecurity]()
The Life-Saving Intersection of Healthcare and Cybersecurity
For all the challenges brought on by COVID-19, one bright spot has been the accelerated development of healthcare technology that is saving lives. A brighter future awaits.
-
![COVID-19: Effective Internal Comms in Unprecedented Times]()
COVID-19: Effective Internal Comms in Unprecedented Times
Forget business as usual. Organizations must ramp up and maintain transparency during this time of crisis to reassure their employees.
-
![5 Steps Critical Access Hospitals Can Take to Save on Orphan Drugs]()
5 Steps Critical Access Hospitals Can Take to Save on Orphan Drugs
Drugs used to treat rare diseases fall outside a federal program that helps rural hospitals afford them. But with the right approach, their pharmacy departments can potentially acquire these specialized pharmaceuticals at a discount from the manufacturers.
-
![How Can We Better Protect Our Medical Devices When It Comes to Cybersecurity?]()
How Can We Better Protect Our Medical Devices When It Comes to Cybersecurity?
Managing Director Brian Stites of FTI Cybersecurity answers a question that few contemplated until recently, but must be seriously considered as more life-saving devices come online. This is the second in our series for National Critical Infrastructure Security and Resilience Month (November).
-
![Managing Export Controls and Sanctions: It's About Who You Know and What You Know]()
Managing Export Controls and Sanctions: It's About Who You Know and What You Know
A patchwork of domestic and international regulations has grown trickier to navigate over the past few years. Even the most mindful companies can stumble.
-
![The Healthcare Industry Needs a Cybersecurity Booster Shot]()
The Healthcare Industry Needs a Cybersecurity Booster Shot
Every industry faces great risk from cyber attack; healthcare is especially vulnerable.
-
![The Costly Risk Everyone Forgets About in M&A]()
The Costly Risk Everyone Forgets About in M&A
Overlooking cybersecurity during due diligence could lead to a rude awakening.
-
![Cutting Through the Rhetoric: What Voters Really Want When It Comes to Healthcare]()
Cutting Through the Rhetoric: What Voters Really Want When It Comes to Healthcare
In the ongoing debate over healthcare costs and coverage, “Medicare for All” is a hot topic within the Democratic Party — and potentially a litmus test for candidates in Democratic primaries. But dive into policy specifics and voters start backing away. FTI Consulting polled American voters to find out what they really want.
-
![How Creative Web Scraping Played a Key Role in a Medicaid Arbitration Case]()
How Creative Web Scraping Played a Key Role in a Medicaid Arbitration Case
It started with a simple question. An arbitration panel asks a statistics expert to testify about the concept of “acceptable statistical precision” in a routine healthcare audit. Who knew that providing an answer would require thinking like a cyberthief?
-
![7 Keys to Making Smart Deals in Today’s Pharma and Biotech Industries]()
7 Keys to Making Smart Deals in Today’s Pharma and Biotech Industries
Personal insights from pharma and biotech executives on unlocking value, protecting IP, and growing business in a climate of M&As.
-
![Investors Eye the Growing Women’s Health Market]()
Investors Eye the Growing Women’s Health Market
What’s driving the influx of funds?
-
![Is Blockchain Healthcare’s Latest Remedy?]()
Is Blockchain Healthcare’s Latest Remedy?
The healthcare industry has long struggled to control soaring costs while maintaining accessibility and transparency. Applying blockchain technology may solve those issues.
-
![The Post-Acute Care Market is Ailing. Is There a Prescription for Investors?]()
The Post-Acute Care Market is Ailing. Is There a Prescription for Investors?
Ronald Greenspan, Leader of FTI Consulting's Real Estate Restructuring practice, and Scott Bingham, Co-leader of U.S. Transaction Services, look at the issues bedeviling post-acute care providers and possible paths forward for concerned stakeholders.
-
![4 Ways Healthcare Providers Can Better Care for Their Patients – And Their Bottom Line]()
4 Ways Healthcare Providers Can Better Care for Their Patients – And Their Bottom Line
U.S. healthcare providers are increasingly adopting a value-based-care model. Here are the factors they should consider while trying to mitigate financial risk.
-
![The Medicine of the Future is Here – And It’s Alive!]()
The Medicine of the Future is Here – And It’s Alive!
For the first time, cell and gene-based therapies are set to enter the U.S. and European markets. Given their potential to combat aggressive cancers and reverse blindness, they promise to be highly disruptive. But for the communicators tasked with explaining their benefits that means new challenges ahead.
-
![Healthcare Heating Up: Investors Bullish on Deals in 2018]()
Healthcare Heating Up: Investors Bullish on Deals in 2018
The new corporate tax rate and other trends are sparking fresh interest in the healthcare market.
-
![Concurrent Surgeries Could Cut Into Your Hospital’s Funding]()
Concurrent Surgeries Could Cut Into Your Hospital’s Funding
Following new guidelines on a common but potentially risky surgical practice is a must for hospitals if they expect to get reimbursed – and save lives.
-
![Understanding Profitable Sales Growth Gets a Little Easier with Price/Volume/Mix Analysis]()
Understanding Profitable Sales Growth Gets a Little Easier with Price/Volume/Mix Analysis
A simpler solution for analyzing how to grow revenue and profitability and the importance of product mix.
-
![What Big Pharma Can Learn from Biotechs]()
What Big Pharma Can Learn from Biotechs
The biotech industry has thrived on innovation and breakthrough research. Now Big Pharma is adopting the best practices of its smaller brethren.
-
![If You Don’t Want to Blow Up Your Healthcare Deal...]()
If You Don’t Want to Blow Up Your Healthcare Deal...
You’re deep into a healthcare acquisition when you suddenly discover their revenue looks off. Way off. Now what do you do?
-
![Re-imagining Employer Healthcare: Transforming Benefits into a Competitive Advantage]()
Re-imagining Employer Healthcare: Transforming Benefits into a Competitive Advantage
How “Self-funding” employer healthcare plans turn benefits into a competitive advantage for companies.
-
![Get Well Soon, Healthcare Providers]()
Get Well Soon, Healthcare Providers
A wave of bankruptcies among stand-alone healthcare providers seems just around the corner. Here’s what distressed firms can do right now to get healthy.
-
![Prescription for a Successful Healthcare Rollup]()
Prescription for a Successful Healthcare Rollup
Private equity investors are buying up physician practices and other fragmented segments of the healthcare market and rolling them into single entities ripe for sale. Here’s what buyers and sellers need to know.
-
![Healthcare Strategy: Integrated Planning Leads to Better Results]()
Healthcare Strategy: Integrated Planning Leads to Better Results
This underutilized strategy can lead to improvements in operational efficiencies, cost savings and patient care.
-
![Wait and See: Investors Yearning to Break Out on Healthcare Deals in 2017]()
Wait and See: Investors Yearning to Break Out on Healthcare Deals in 2017
As evidenced at the 2017 JP Morgan Healthcare Conference, a number of uncertainties in the healthcare market are keeping investment dollars tight and point toward a major correction.
-
![The Urgent Need for Urgent Care]()
The Urgent Need for Urgent Care
One key to controlling soaring health care costs in the U.S.? Urgent Care centers—the middle ground between primary and emergency treatment. Here’s ten ways to make it work
-
![How to Invest in America’s Most Controversial New Industry without Losing Your Reputation]()
How to Invest in America’s Most Controversial New Industry without Losing Your Reputation
When a pair of leading institutional investors set out to win a state license to open New York City’s first medical marijuana dispensary, they turned to an FTI Consultant with a unique background as a journalist covering the illegal drug trade. His advice? Differentiate your brand.
-
![Will New Medicare Law Get Lab Technicians Heated Up?]()
Will New Medicare Law Get Lab Technicians Heated Up?
The government’s demand for reams of data from clinical labs is meant to help curb the cost of Medicare reimbursement for diagnostic testing. But it threatens to overwhelm the industry. Here’s what labs should know when trading big data for big bucks.
-
![Measuring the Future of Healthcare]()
Measuring the Future of Healthcare
The need for healthcare transformation has been widely recognized for some time and was a driving force behind the 2010 Affordable Care Act ("ACA").
-
![Biotech and Big Pharma: Keys to a Successful M&A]()
Biotech and Big Pharma: Keys to a Successful M&A
Despite the recent (and largely negative) press around high drug prices, concerns about the possibility of a biotech bubble that could one day (soon?) burst and the autumn 2015 selloff in the health sector that some called the worst in the past four years ...
-
![The Rise of Analytics in E-discovery:]()
The Rise of Analytics in E-discovery:
There were just over 295,000 civil suits filed in U.S. district courts in 2014, an increase of 4 percent over 2013. On top of that, there were another 81,000 criminal cases (including fraud) filed.
-
![The Cautious Investors’ Guide to Brazil]()
The Cautious Investors’ Guide to Brazil
It’s no secret that Brazil has been going through hard times and that investors — with good reason — regard the country as a high-risk environment.
-
![MEMO TO PHARMA: Don’t Get Complacent (DSCSA Deadlines Loom)]()
MEMO TO PHARMA: Don’t Get Complacent (DSCSA Deadlines Loom)
According to the World Health Organization ("WHO"), from 1 percent to 10 percent of drugs sold around the world today are counterfeits, and about 50 percent of medicines purchased ...
-
![Mobile Health: In the Middle of the Beginning]()
Mobile Health: In the Middle of the Beginning
Healthcare and life sciences, more than any other sector in the world, are in an intense period of innovation and change. New science, technologies, regulations and reimbursement policies are pushing providers, payers and patients to rethink ...
-
![What Are More Than a Billion Insured Patients Worth?]()
What Are More Than a Billion Insured Patients Worth?
China’s population suffers from a debilitating lack of access to healthcare. To improve it, the government last year opened up the sector to foreign investors who are rushing in despite daunting challenges.
-
![Five Questions to Ask Before Your Next Healthcare Data Breach]()
Five Questions to Ask Before Your Next Healthcare Data Breach
In early February 2015, Anthem, one of America’s largest health insurers, revealed that it had been attacked, with the personal information of some 80 million people exposed.
-
![The Rise of Telemedicine: Yes, There’s a Virtual Doctor in the House]()
The Rise of Telemedicine: Yes, There’s a Virtual Doctor in the House
As late as the 1960s, doctors often went to patient homes. A decade later, comparing something with “a doctor’s house call” had become a sarcastic comment on the loss of the personal touch.
-
![The ACA and Big Pharma After the 2014 Mid-Term Elections]()
The ACA and Big Pharma After the 2014 Mid-Term Elections
Shortly after the Republican sweep of the November mid-term elections, FTI Consulting’s Strategic Communications segment held a panel to discuss the election’s...
-
![It Takes a Community to Improve Healthcare]()
It Takes a Community to Improve Healthcare
The Affordable Care Act was designed to lower the cost of healthcare while improving its quality. One requirement for achieving both goals is to have individuals make better decisions about their own health and for the health of their community.
-
![Clinical Integration: Collaborating for Value-Based Care]()
Clinical Integration: Collaborating for Value-Based Care
Bringing together physicians, hospitals and clinics under one umbrella can bring real benefits to patients, doctors and payers.
-
![The Life Science Boom]()
The Life Science Boom
Last year was the Year of the Deal in life sciences. There were 43 U.S. healthcare initial public offerings (IPO), triple the number in 2012.
-
![A Roadmap for Healthcare Convergence]()
A Roadmap for Healthcare Convergence
The U.S. healthcare industry is undergoing a wave of radical change and disruptive innovation.
-
![The Long (and Expensive) Good-Bye]()
The Long (and Expensive) Good-Bye
The 2010 Affordable Care Act was designed (in part) to reduce the rising and unsustainable cost of healthcare while improving its quality. One area in which this value equation is vividly out of whack is end-of-life care.
-
![Is “Business Ethics” an Oxymoron?]()
Is “Business Ethics” an Oxymoron?
Scandals. Fines. Show trials. These days, just doing business can appear almost criminal. While government-imposed regulation can soothe the public’s ire, it can also create burdensome costs and competitive disadvantages. To survive, businesses must perform reputational due diligence and create self-policing organizational cultures.
-
![Angels in the Analytics]()
Angels in the Analytics
Boston Medical Center was the city’s largest safety-net provider. But with healthcare insurance reform, state funding dried up, and hospital revenue was in free-fall. Here’s how it turned a 2010 operating loss of $34 million into a $2.5 million gain in two years by deploying advanced analytics to inform decision-making at all levels.
-
![Population Health Management to the Rescue]()
Population Health Management to the Rescue
Late last year, a large U.S. regional health plan faced one of its toughest challenges in decades.
-
![Rx for Transformation]()
Rx for Transformation
Strategies and tactics to succeed in the turbulent U.S. healthcare market
-
![Nowhere to Hide]()
Nowhere to Hide
With the U.S. government cracking down on Medicare fraud, self-screening offers a smart way for healthcare providers to assess and reduce their risks.
-
![2013 Life Sciences Investor Survey]()
2013 Life Sciences Investor Survey
The FTI Consulting third annual Life Sciences Investor Survey, a study conducted by the Strategic Communication practice, assessed U.S. and European investors’ outlook on the investment climate in life sciences and, specifically, their expectations for the sector with regard to transactions, drug development pipelines, subsector performance and geographic growth prospects.
-
![Better Healthcare Through Clinical Integration]()
Better Healthcare Through Clinical Integration
A Discussion with Singing River Health System Facilitated by Phil Polakoff, M.D., FTI Consulting Chief Medical Executive
-
![Prescription For Integration]()
Prescription For Integration
Many U.S. hospitals and physicians are waiting on the sidelines to see if healthcare reform legislation will become a reality. But such hesitancy will put their economic health at risk — regardless of what shape the legislation finally takes.
-
![Bridging The Divide]()
Bridging The Divide
Health insurance CEOs are caught in a tug of war between companies whose employees want affordable care and healthcare providers that desire a decent return on their services. Yet many answers can be found in Europe, South America and Canada — and even the United States.
-
![A World Of Ideas]()
A World Of Ideas
Around the globe, innovations in healthcare are coming from private enterprise. These successful projects could lead the way to many others.
-
![What's In The Pipeline?]()
What's In The Pipeline?
Facing negative publicity and investor wariness, pharmaceutical companies need to communicate how investments in R&D will deliver meaningful future growth.
-
![Working Well]()
Working Well
Helping employees kick unhealthy habits and prevent disease has benefits for companies too, and businesses around the world are stepping up their efforts.
-
![Healthcare In A Box]()
Healthcare In A Box
One company’s simple but effective model for improving healthcare delivery in remote, impoverished locations is having an outsize impact.
-
![A Hard Look At Costs]()
A Hard Look At Costs
As care costs rise, so does the gap between those who can and cannot afford treatment. Key industry players must come onboard to drive down fees and increase healthcare accessibility.
-
![Understanding the Foreign Corruption Dragnet]()
Understanding the Foreign Corruption Dragnet
As regulators dedicate more resources to global prosecutions and enforcement actions, FTI looks at what businesses, senior executives and boards can do to educate themselves and their companies
-560x340.jpg)
-560x340.jpg)
-560x340.jpg)
Home Is Where The Health Is
Jul 2020
What mid- to long-term investment opportunities are expected to emerge in the home healthcare market following COVID-19?
Snapshot of the Pandemic: Is the Weather Affecting Your Social Distancing?
Jul 2020
An FTI review of social distancing complaints in New York City reveals how much the weather can impact behavior. What does it mean for Americans as the summer months unfold?
The Life-Saving Intersection of Healthcare and Cybersecurity
May 2020
For all the challenges brought on by COVID-19, one bright spot has been the accelerated development of healthcare technology that is saving lives. A brighter future awaits.
COVID-19: Effective Internal Comms in Unprecedented Times
Mar 2020
Forget business as usual. Organizations must ramp up and maintain transparency during this time of crisis to reassure their employees.
5 Steps Critical Access Hospitals Can Take to Save on Orphan Drugs
Nov 2019
Drugs used to treat rare diseases fall outside a federal program that helps rural hospitals afford them. But with the right approach, their pharmacy departments can potentially acquire these specialized pharmaceuticals at a discount from the manufacturers.
How Can We Better Protect Our Medical Devices When It Comes to Cybersecurity?
Nov 2019
Managing Director Brian Stites of FTI Cybersecurity answers a question that few contemplated until recently, but must be seriously considered as more life-saving devices come online. This is the second in our series for National Critical Infrastructure Security and Resilience Month (November).
Managing Export Controls and Sanctions: It's About Who You Know and What You Know
Nov 2019
A patchwork of domestic and international regulations has grown trickier to navigate over the past few years. Even the most mindful companies can stumble.
The Healthcare Industry Needs a Cybersecurity Booster Shot
Aug 2019
Every industry faces great risk from cyber attack; healthcare is especially vulnerable.
The Costly Risk Everyone Forgets About in M&A
Jul 2019
Overlooking cybersecurity during due diligence could lead to a rude awakening.
Cutting Through the Rhetoric: What Voters Really Want When It Comes to Healthcare
Mar 2019
In the ongoing debate over healthcare costs and coverage, “Medicare for All” is a hot topic within the Democratic Party — and potentially a litmus test for candidates in Democratic primaries. But dive into policy specifics and voters start backing away. FTI Consulting polled American voters to find out what they really want.
How Creative Web Scraping Played a Key Role in a Medicaid Arbitration Case
Feb 2019
It started with a simple question. An arbitration panel asks a statistics expert to testify about the concept of “acceptable statistical precision” in a routine healthcare audit. Who knew that providing an answer would require thinking like a cyberthief?
7 Keys to Making Smart Deals in Today’s Pharma and Biotech Industries
Feb 2019
Personal insights from pharma and biotech executives on unlocking value, protecting IP, and growing business in a climate of M&As.
Is Blockchain Healthcare’s Latest Remedy?
Aug 2018
The healthcare industry has long struggled to control soaring costs while maintaining accessibility and transparency. Applying blockchain technology may solve those issues.
The Post-Acute Care Market is Ailing. Is There a Prescription for Investors?
Jun 2018
Ronald Greenspan, Leader of FTI Consulting's Real Estate Restructuring practice, and Scott Bingham, Co-leader of U.S. Transaction Services, look at the issues bedeviling post-acute care providers and possible paths forward for concerned stakeholders.
4 Ways Healthcare Providers Can Better Care for Their Patients – And Their Bottom Line
Aug 2018
U.S. healthcare providers are increasingly adopting a value-based-care model. Here are the factors they should consider while trying to mitigate financial risk.
The Medicine of the Future is Here – And It’s Alive!
Apr 2018
-150x150.jpg)
For the first time, cell and gene-based therapies are set to enter the U.S. and European markets. Given their potential to combat aggressive cancers and reverse blindness, they promise to be highly disruptive. But for the communicators tasked with explaining their benefits that means new challenges ahead.
Healthcare Heating Up: Investors Bullish on Deals in 2018
Feb 2018
The new corporate tax rate and other trends are sparking fresh interest in the healthcare market.
Concurrent Surgeries Could Cut Into Your Hospital’s Funding
Jan 2018
Following new guidelines on a common but potentially risky surgical practice is a must for hospitals if they expect to get reimbursed – and save lives.
Understanding Profitable Sales Growth Gets a Little Easier with Price/Volume/Mix Analysis
Dec 2017
A simpler solution for analyzing how to grow revenue and profitability and the importance of product mix.
What Big Pharma Can Learn from Biotechs
Dec 2017
The biotech industry has thrived on innovation and breakthrough research. Now Big Pharma is adopting the best practices of its smaller brethren.
If You Don’t Want to Blow Up Your Healthcare Deal...
Sep 2017
You’re deep into a healthcare acquisition when you suddenly discover their revenue looks off. Way off. Now what do you do?
Re-imagining Employer Healthcare: Transforming Benefits into a Competitive Advantage
May 2017
How “Self-funding” employer healthcare plans turn benefits into a competitive advantage for companies.
Get Well Soon, Healthcare Providers
Apr 2017
-150x150.jpg)
A wave of bankruptcies among stand-alone healthcare providers seems just around the corner. Here’s what distressed firms can do right now to get healthy.
Prescription for a Successful Healthcare Rollup
Mar 2017
-150x150.jpg)
Private equity investors are buying up physician practices and other fragmented segments of the healthcare market and rolling them into single entities ripe for sale. Here’s what buyers and sellers need to know.
Healthcare Strategy: Integrated Planning Leads to Better Results
Mar 2017
This underutilized strategy can lead to improvements in operational efficiencies, cost savings and patient care.
Wait and See: Investors Yearning to Break Out on Healthcare Deals in 2017
Feb 2017
As evidenced at the 2017 JP Morgan Healthcare Conference, a number of uncertainties in the healthcare market are keeping investment dollars tight and point toward a major correction.
The Urgent Need for Urgent Care
Sep 2016
One key to controlling soaring health care costs in the U.S.? Urgent Care centers—the middle ground between primary and emergency treatment. Here’s ten ways to make it work
How to Invest in America’s Most Controversial New Industry without Losing Your Reputation
Apr 2016
When a pair of leading institutional investors set out to win a state license to open New York City’s first medical marijuana dispensary, they turned to an FTI Consultant with a unique background as a journalist covering the illegal drug trade. His advice? Differentiate your brand.
Will New Medicare Law Get Lab Technicians Heated Up?
Apr 2016
The government’s demand for reams of data from clinical labs is meant to help curb the cost of Medicare reimbursement for diagnostic testing. But it threatens to overwhelm the industry. Here’s what labs should know when trading big data for big bucks.
Measuring the Future of Healthcare
Feb 2016
The need for healthcare transformation has been widely recognized for some time and was a driving force behind the 2010 Affordable Care Act ("ACA").
Biotech and Big Pharma: Keys to a Successful M&A
Jan 2016
Despite the recent (and largely negative) press around high drug prices, concerns about the possibility of a biotech bubble that could one day (soon?) burst and the autumn 2015 selloff in the health sector that some called the worst in the past four years ...
The Rise of Analytics in E-discovery:
Dec 2015
There were just over 295,000 civil suits filed in U.S. district courts in 2014, an increase of 4 percent over 2013. On top of that, there were another 81,000 criminal cases (including fraud) filed.
The Cautious Investors’ Guide to Brazil
Dec 2015
It’s no secret that Brazil has been going through hard times and that investors — with good reason — regard the country as a high-risk environment.
MEMO TO PHARMA: Don’t Get Complacent (DSCSA Deadlines Loom)
Nov 2015
According to the World Health Organization ("WHO"), from 1 percent to 10 percent of drugs sold around the world today are counterfeits, and about 50 percent of medicines purchased ...
Mobile Health: In the Middle of the Beginning
Jul 2015
Healthcare and life sciences, more than any other sector in the world, are in an intense period of innovation and change. New science, technologies, regulations and reimbursement policies are pushing providers, payers and patients to rethink ...
What Are More Than a Billion Insured Patients Worth?
Jun 2015
China’s population suffers from a debilitating lack of access to healthcare. To improve it, the government last year opened up the sector to foreign investors who are rushing in despite daunting challenges.
Five Questions to Ask Before Your Next Healthcare Data Breach
Mar 2015
In early February 2015, Anthem, one of America’s largest health insurers, revealed that it had been attacked, with the personal information of some 80 million people exposed.
The Rise of Telemedicine: Yes, There’s a Virtual Doctor in the House
Feb 2015
As late as the 1960s, doctors often went to patient homes. A decade later, comparing something with “a doctor’s house call” had become a sarcastic comment on the loss of the personal touch.
The ACA and Big Pharma After the 2014 Mid-Term Elections
Jan 2015
Shortly after the Republican sweep of the November mid-term elections, FTI Consulting’s Strategic Communications segment held a panel to discuss the election’s...
It Takes a Community to Improve Healthcare
Dec 2014
The Affordable Care Act was designed to lower the cost of healthcare while improving its quality. One requirement for achieving both goals is to have individuals make better decisions about their own health and for the health of their community.
Clinical Integration: Collaborating for Value-Based Care
May 2014
Bringing together physicians, hospitals and clinics under one umbrella can bring real benefits to patients, doctors and payers.
The Life Science Boom
May 2014
Last year was the Year of the Deal in life sciences. There were 43 U.S. healthcare initial public offerings (IPO), triple the number in 2012.
A Roadmap for Healthcare Convergence
May 2014
The U.S. healthcare industry is undergoing a wave of radical change and disruptive innovation.
The Long (and Expensive) Good-Bye
Mar 2014
The 2010 Affordable Care Act was designed (in part) to reduce the rising and unsustainable cost of healthcare while improving its quality. One area in which this value equation is vividly out of whack is end-of-life care.
Is “Business Ethics” an Oxymoron?
Feb 2014
Scandals. Fines. Show trials. These days, just doing business can appear almost criminal. While government-imposed regulation can soothe the public’s ire, it can also create burdensome costs and competitive disadvantages. To survive, businesses must perform reputational due diligence and create self-policing organizational cultures.
Angels in the Analytics
Nov 2013
Boston Medical Center was the city’s largest safety-net provider. But with healthcare insurance reform, state funding dried up, and hospital revenue was in free-fall. Here’s how it turned a 2010 operating loss of $34 million into a $2.5 million gain in two years by deploying advanced analytics to inform decision-making at all levels.
Population Health Management to the Rescue
Oct 2013
Late last year, a large U.S. regional health plan faced one of its toughest challenges in decades.
Rx for Transformation
Sep 2013
Strategies and tactics to succeed in the turbulent U.S. healthcare market
Nowhere to Hide
Jul 2013
With the U.S. government cracking down on Medicare fraud, self-screening offers a smart way for healthcare providers to assess and reduce their risks.
2013 Life Sciences Investor Survey
Jun 2013
The FTI Consulting third annual Life Sciences Investor Survey, a study conducted by the Strategic Communication practice, assessed U.S. and European investors’ outlook on the investment climate in life sciences and, specifically, their expectations for the sector with regard to transactions, drug development pipelines, subsector performance and geographic growth prospects.
Better Healthcare Through Clinical Integration
Jun 2013
A Discussion with Singing River Health System Facilitated by Phil Polakoff, M.D., FTI Consulting Chief Medical Executive
Prescription For Integration
Sep 2011
Many U.S. hospitals and physicians are waiting on the sidelines to see if healthcare reform legislation will become a reality. But such hesitancy will put their economic health at risk — regardless of what shape the legislation finally takes.
Time For Change
Sep 2011
Improving value in the United Kingdom’s National Health Service is an economic necessity, and while the government’s unpopular plan may have been watered down, it may yet serve as a model of what other cash-strapped health systems must do. And where private providers can help, they will be in demand.
Unite And Conquer
Sep 2011
Getting bigger is one way to cut costs and improve care, but merged hospitals often fail to achieve one or both goals. Michael Dowling, president and CEO of North Shore-LIJ Health System, discusses what it takes to integrate operations and cultures.
All Hands On Deck
Sep 2011
Accountable care organizations are the talk of the industry in the United States, but precious few actually exist — and that means few guideposts for getting an ACO up and running. That hasn’t stopped this health system.
The Wrong Lessons
Sep 2011
The U.S. government, which has a history of responding to economic crises with counterproductive strategies, has done it again, argues this former regulator, who recommends a more effective path.
Bridging The Divide
Sep 2011
Health insurance CEOs are caught in a tug of war between companies whose employees want affordable care and healthcare providers that desire a decent return on their services. Yet many answers can be found in Europe, South America and Canada — and even the United States.
A World Of Ideas
Sep 2011
Around the globe, innovations in healthcare are coming from private enterprise. These successful projects could lead the way to many others.
What's In The Pipeline?
Sep 2011
Facing negative publicity and investor wariness, pharmaceutical companies need to communicate how investments in R&D will deliver meaningful future growth.
Working Well
Sep 2011
Helping employees kick unhealthy habits and prevent disease has benefits for companies too, and businesses around the world are stepping up their efforts.
Healthcare In A Box
Sep 2011
One company’s simple but effective model for improving healthcare delivery in remote, impoverished locations is having an outsize impact.
A Hard Look At Costs
Sep 2011
As care costs rise, so does the gap between those who can and cannot afford treatment. Key industry players must come onboard to drive down fees and increase healthcare accessibility.
Understanding the Foreign Corruption Dragnet
Apr 2010
As regulators dedicate more resources to global prosecutions and enforcement actions, FTI looks at what businesses, senior executives and boards can do to educate themselves and their companies
Cutting U.S. Healthcare Costs
Oct 2009
The FTI Journal recently convened a group of FTI experts from varied yet connected backgrounds and disciplines – from performance improvement and restructuring, to economic consulting and strategic communications – for a discussion about the state of healthcare in the United States and around the world, with a focus on what’s driving increased spending, and how to slow its growth.
Aerospace & Defense
Agriculture
Automotive
Construction
Energy & Chemicals
Environmental
Financial Services
Government & Public Contracts
Healthcare & Life Sciences
Hospitality, Gaming & Leisure
Information Technology
Insurance
Media & Entertainment
Mining
Real Estate
Retail
Telecommunications
Transportation
Business Transformation & Transactions
Communications & Reputation
Economics & Policy
Cybersecurity
Global Trade
Management & Leadership
Regulation & Governance
Restructuring & Turnaround
Risk & Litigation
Technology & Data
About the FTI Journal
FTI Journal offers deep and engaging insights to contextualize the issues that matter. With a global lens, the publication explores topics that will impact the risks your business faces and its reputation. It’s the go-to source for the actionable advice you need to solve complex problems.
